Identification of Vyndaqel:
No description |
Search images on Google Product Monograph
Active Ingredients:
- tafamidis meglumine, 20 MG
DIN: 02495732
Dosage Form(s): CAPSULE
Route(s) of Administration: ORAL
Schedule: Prescription
Company: PFIZER CANADA ULC
ATC:
- N07 - OTHER NERVOUS SYSTEM DRUGS (ATC, WHO, Wiki)
- N07X - OTHER NERVOUS SYSTEM DRUGS (ATC, WHO)
- N07XX - Other nervous system drugs (ATC, WHO)
- N07XX08 - TAFAMIDIS (WHO)
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 120
Pharmaceutical standard: MFR